Sensus Healthcare (SRTS) Net Income towards Common Stockholders (2016 - 2025)

Sensus Healthcare's Net Income towards Common Stockholders history runs 10 years deep, the most recent figure standing at -$3.2 million for Q4 2025.

• On a quarterly basis, Net Income towards Common Stockholders fell 304.85% year-over-year to -$3.2 million in Q4 2025; TTM through Mar 2026 was -$5.1 million, a 385.79% decrease from a year earlier, with the FY2025 full-year figure at -$7.7 million, down 216.13% from the prior year.
• Net Income towards Common Stockholders slipped to -$3.2 million in Q4 2025 per SRTS's latest filing, from -$943000.0 in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $5.3 million in Q4 2021 and bottomed at -$631.3 million in Q1 2022.
• The 5-year median for Net Income towards Common Stockholders is -$42000.0 (2021), against an average of -$31.0 million.
• Across the five-year window, Net Income towards Common Stockholders surged 1985.49% in 2021 and slumped 56517.94% in 2022, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $5.3 million in 2021, then sank by 46.8% to $2.8 million in 2022, then jumped by 48.82% to $4.2 million in 2023, then sank by 63.28% to $1.5 million in 2024, then plunged by 304.85% to -$3.2 million in 2025.
• Per Business Quant, the three latest SRTS Net Income towards Common Stockholders figures stand at -$3.2 million (Q4 2025), -$943000.0 (Q3 2025), and -$1.0 million (Q2 2025).